Ocon medical Develops, manufactures, and commercializes innovative women’s health products.
based on its proprietary flexible Nitinol platform, IUB (Intra Uterine Ball).
The first product, the Ballerine is a long term (5 years in current markets) copper-based hormone-free intrauterine contraceptive. It is currently sold in 30 countries across Europe, South Africa, and Israel. To date, over ~95,000 women have used Ballerine.
The next product based on the same platform is a treatment of abnormal uterine bleeding (AUB) with SEAD (Spherical Endometrial Ablation Device), the product is in PHASE IIa clinical study.
Other APIs could be added to the delivery system, including a hormone-free, long-acting agent or other drugs that require targeted delivery in the uterine cavity.